Abgenix to Present at Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference
08 Juni 2005 - 11:30PM
PR Newswire (US)
Abgenix to Present at Goldman Sachs Twenty-Sixth Annual Global
Healthcare Conference FREMONT, Calif., June 8
/PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) today
announced that it will present at the Goldman Sachs 26th Annual
Healthcare Conference on Tuesday, June 14, 2005 at 10:25 a.m. PT,
1:25 p.m. ET. The presentation will be webcast live and may be
accessed by visiting the Abgenix website at
http://www.abgenix.com/. A replay of the webcast will also be
available on the company's website until Tuesday, June 28, 2005.
Bill Ringo, president and chief executive officer of Abgenix, will
provide an overview of the company's antibody development
activities. About Abgenix Abgenix is a biopharmaceutical company
focused on the discovery, development and manufacturing of human
therapeutic antibodies. The company's antibody development platform
includes a leading technology and state-of-the- art manufacturing
capabilities that enable the rapid generation, selection and
production of high affinity, fully human antibody product
candidates to a variety of disease targets. Abgenix leverages its
leadership position in human antibody technology to build a
diversified product portfolio through its own development efforts
and the establishment of collaborations with multiple
pharmaceutical and biotechnology companies. For more information on
Abgenix, visit the company's website at http://www.abgenix.com/.
DATASOURCE: Abgenix, Inc. CONTACT: Aisha Santiago, Corporate
Communications & Investor Relations of Abgenix, Inc.,
+1-510-284-6858 or +1-510-284-6605; or E. Blair Schoeb, Corporate
Communications, +1-917-432-9275, for Abgenix, Inc. Web site:
http://www.abgenix.com/
Copyright
Abgenix (NASDAQ:ABGX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Abgenix (NASDAQ:ABGX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Abgenix (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Abgenix, (MM) News-Artikel